GO:0006754 ATP biosynthetic process: Energy Production Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006754 ATP biosynthetic process describes the chemical reactions and pathways that result in the formation of ATP, the universal energy currency of the cell.
• ATP can be synthesized by substrate-level phosphorylation, oxidative phosphorylation, and decarboxylation phosphorylation, with oxidative phosphorylation being the major route in aerobic organisms [1,5].
• The process is essential for maintaining cellular energy homeostasis and is tightly regulated by fuel availability and mitochondrial function.
• Dysregulation of ATP synthesis is linked to cardiotoxicity, neurodegenerative disorders, and cancer metabolism.
• Key genes involved include mitochondrial ATP synthase subunits (e.g., ATP5F1A, ATP5F1B), glycolytic enzymes (e.g., PKM, GAPDH), and creatine kinases (e.g., CKB) [1,6].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of ATP biosynthetic pathways in health and disease [1,3].
Description
ATP biosynthetic process (GO:0006754) is a fundamental biological process that encompasses all chemical reactions and pathways leading to the formation of adenosine 5'-triphosphate (ATP), the primary energy carrier in cells. ATP is required for countless cellular activities, including muscle contraction, ion transport, and biosynthesis, and its production is therefore central to life [1,2]. The process occurs through several mechanisms, including substrate-level phosphorylation in glycolysis and the tricarboxylic acid cycle, oxidative phosphorylation in mitochondria, and decarboxylation phosphorylation in certain anaerobic bacteria [1,5]. Understanding how ATP is synthesized and how this process is regulated is critical for researchers studying metabolism, mitochondrial function, and diseases ranging from heart failure to cancer [3,4]. This article provides a comprehensive overview of the ATP biosynthetic process, its molecular machinery, associated genes, and the experimental models used to investigate it.
ATP biosynthetic process At A Glance
| GO ID | GO:0006754 |
|---|---|
| GO term | ATP biosynthetic process |
| Ontology | biological_process |
| Synonym | ATP anabolism, ATP biosynthesis, ATP formation, ATP regeneration, ATP synthesis |
| Major function | Production of ATP, the primary energy currency of the cell |
| Key pathways | Substrate-level phosphorylation, oxidative phosphorylation, decarboxylation phosphorylation |
| Cellular location | Mitochondria, cytoplasm, and bacterial membranes |
| Related diseases | Cardiotoxicity, neurodegenerative disorders, cancer |
What Is GO:0006754?
The ATP biosynthetic process (GO:0006754) is defined as the chemical reactions and pathways that result in the formation of ATP, a universally important coenzyme and enzyme regulator. This process includes both the direct synthesis of ATP from ADP and inorganic phosphate and the regeneration of ATP from its breakdown products [1,2]. It is a core energy-generating process that occurs in all living organisms, with variations in the specific pathways used depending on the organism and environmental conditions.
Why Is ATP biosynthetic process Important in Cell Biology?
ATP biosynthetic process is vital because ATP is the universal energy currency that powers nearly all cellular activities, from biosynthesis to signal transduction [1,2]. Without a continuous supply of ATP, cells cannot maintain ion gradients, synthesize macromolecules, or perform mechanical work. Consequently, defects in ATP synthesis are associated with a wide range of human diseases, including mitochondrial myopathies, heart failure, and cancer [3,4]. Moreover, understanding ATP biosynthesis is fundamental to metabolic research, drug development, and the design of therapies targeting energy metabolism.
• ATP is required for muscle contraction, nerve impulse propagation, and active transport.
• Oxidative phosphorylation in mitochondria produces the majority of ATP in aerobic cells [1,3].
• Substrate-level phosphorylation provides rapid ATP during intense exercise or hypoxia.
• Decarboxylation phosphorylation allows ATP synthesis in certain anaerobic bacteria.
• Dysregulation of ATP synthesis contributes to cardiotoxicity caused by drugs like bevacizumab.
• ATP synthesis is a target for cancer therapy because tumor cells often rely on glycolysis.
• Mitochondrial ATP production declines with age and in neurodegenerative diseases.
• Protein adenylylation, a post-translational modification using ATP, regulates signaling.
• GTP and ATP hydrolysis are coupled in many biological processes, including protein synthesis.
• Purinergic signaling, mediated by ATP and its metabolites, influences numerous physiological functions [2,7].
What Happens During ATP biosynthetic process?
Substrate-level phosphorylation
In simple terms: This is a direct way to make ATP by transferring a phosphate group from a high-energy molecule to ADP.
Substrate-level phosphorylation occurs during glycolysis and the citric acid cycle, where enzymes such as pyruvate kinase and succinyl-CoA synthetase catalyze the transfer of a phosphate group from a substrate to ADP, forming ATP. This mechanism does not require oxygen and is essential for rapid ATP production under anaerobic conditions.
Oxidative phosphorylation
In simple terms: This is the main way cells make ATP using the energy from electrons and oxygen.
Oxidative phosphorylation takes place in the inner mitochondrial membrane and involves the electron transport chain and ATP synthase. Electrons from NADH and FADH2 are passed through a series of protein complexes, creating a proton gradient that drives ATP synthesis by ATP synthase [1,3]. This process generates the bulk of ATP in aerobic organisms.
Decarboxylation phosphorylation
In simple terms: Some bacteria make ATP by using the energy released from decarboxylation reactions.
Decarboxylation phosphorylation is a mechanism used by certain anaerobic bacteria, such as Propionigenium modestum, where the decarboxylation of a substrate is coupled to ATP synthesis via a membrane-bound enzyme complex. This pathway highlights the diversity of ATP biosynthetic strategies in nature.
ATP regeneration and storage
In simple terms: ATP can be regenerated from ADP and stored in forms like phosphocreatine.
ATP is continuously regenerated from ADP and inorganic phosphate to meet cellular demand. In muscle and brain, phosphocreatine serves as a rapid energy buffer, regenerating ATP via creatine kinase. Additionally, ATP can be stored in secretory vesicles and released for purinergic signaling [2,7].
Key Genes Involved in GO:0006754 ATP biosynthetic process
The following genes encode key enzymes and subunits involved in the ATP biosynthetic process, from glycolysis to oxidative phosphorylation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP5F1A | Mitochondrial ATP synthase F1 subunit alpha | Mutations linked to mitochondrial diseases; target for metabolic studies |
| ATP5F1B | Mitochondrial ATP synthase F1 subunit beta | Catalytic subunit of ATP synthase; essential for oxidative phosphorylation |
| ATP5MC1 | Mitochondrial ATP synthase membrane subunit c | Forms the proton channel; involved in mitochondrial disorders |
| PKM | Pyruvate kinase M1/2 | Catalyzes substrate-level phosphorylation in glycolysis; isoform switch in cancer |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | Glycolytic enzyme; also involved in apoptosis and DNA repair |
| CKB | Creatine kinase B | Regenerates ATP from phosphocreatine in brain and muscle |
| CKMT1A | Creatine kinase, mitochondrial 1A | Mitochondrial creatine kinase; couples energy production to utilization |
| NDUFA1 | NADH:ubiquinone oxidoreductase subunit A1 | Component of complex I; mutations cause mitochondrial disease |
| SDHA | Succinate dehydrogenase complex flavoprotein subunit A | Part of complex II; links TCA cycle to electron transport |
| UQCRC1 | Ubiquinol-cytochrome c reductase core protein 1 | Component of complex III; involved in electron transfer |
| COX4I1 | Cytochrome c oxidase subunit 4I1 | Component of complex IV; regulates cytochrome c oxidase activity |
| ATP5PF | ATP synthase peripheral stalk subunit F6 | Regulates ATP synthase; involved in mitochondrial bioenergetics |
| ENO1 | Enolase 1 | Glycolytic enzyme; multifunctional protein in energy metabolism |
| LDHA | Lactate dehydrogenase A | Converts pyruvate to lactate; important for anaerobic ATP production |
| PDHA1 | Pyruvate dehydrogenase E1 subunit alpha 1 | Links glycolysis to TCA cycle; regulates flux into oxidative phosphorylation |
| ACO2 | Aconitase 2 | TCA cycle enzyme; mutations cause infantile cerebellar-retinal degeneration |
| IDH3A | Isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha | TCA cycle enzyme; contributes to NADH production for ATP synthesis |
How Is ATP biosynthetic process Regulated?
ATP biosynthetic process is regulated at multiple levels to match energy supply with demand. Mitochondrial fuel utilization is shaped by substrate availability and hormonal signals, such as insulin and glucagon. The AMP-activated protein kinase (AMPK) senses cellular energy status and promotes ATP-producing pathways while inhibiting ATP-consuming processes. Additionally, protein adenylylation, a reversible post-translational modification, can modulate the activity of enzymes involved in ATP synthesis. Purinergic signaling also provides feedback regulation, as extracellular ATP and its metabolites influence cellular responses [2,7].
ATP biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP5F1A | Mitochondrial myopathy, neuropathy, ataxia | Knockout or point-mutation in cell lines; oxidative phosphorylation assays |
| PKM | Cancer metabolism (Warburg effect) | Knockout and overexpression in cancer cell lines; metabolic flux analysis |
| CKB | Neurodegeneration, muscle energy deficit | Knock-in of patient mutations; ATP regeneration assays |
| NDUFA1 | Leigh syndrome, mitochondrial complex I deficiency | Knockout in neuronal cells; respirometry |
| SDHA | Paraganglioma, pheochromocytoma | Knockout in adrenal cell models; succinate dehydrogenase activity assays |
Cardiotoxicity and heart failure
Impaired ATP synthesis in cardiomyocytes contributes to heart failure and drug-induced cardiotoxicity. For example, bevacizumab, an anti-VEGF antibody used in cancer therapy, can cause cardiotoxicity that is mitigated by ATP supplementation in experimental models. This highlights the critical role of ATP biosynthesis in maintaining cardiac function.
Cancer metabolism
Cancer cells often reprogram their metabolism to support rapid growth, frequently relying on aerobic glycolysis (the Warburg effect) for ATP production even in the presence of oxygen. This metabolic shift makes ATP biosynthetic pathways attractive targets for anticancer therapy.
Neurodegenerative disorders
Neurons are highly dependent on mitochondrial ATP synthesis, and defects in oxidative phosphorylation are linked to neurodegenerative diseases such as Parkinson's and Alzheimer's. Reduced ATP production can lead to synaptic dysfunction and neuronal death.
Mitochondrial myopathies
Mutations in genes encoding components of the electron transport chain or ATP synthase cause mitochondrial myopathies, characterized by muscle weakness and exercise intolerance due to insufficient ATP production [1,3].
From ATP biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATP5F1A impair oxidative phosphorylation? | Knockout cell line (e.g., HEK293T) with Seahorse assay |
| How does a point mutation in PKM affect glycolysis and ATP production? | Point-mutation knock-in via CRISPR in cancer cells |
| Can overexpression of CKB rescue ATP levels in neurons? | Overexpression cell model with ATP luminescence assays |
| What is the role of NDUFA1 in complex I assembly? | Tagged knock-in for affinity purification and proteomics |
| Does a disease-associated SDHA mutation alter TCA cycle flux? | Knock-in of mutant SDHA in cell lines; metabolomics |
| Which genes are essential for ATP synthesis under hypoxia? | CRISPR library screening with ATP sensor readout |
How to Study the ATP biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Seahorse assay | Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) | Assessing mitochondrial function and glycolysis in live cells |
| ATP luminescence | Total cellular ATP concentration | Quantifying ATP levels after genetic or drug treatment |
| Metabolomics | Levels of metabolites in glycolysis and TCA cycle | Identifying metabolic bottlenecks in ATP production |
| Isotope tracing | Flux of labeled substrates through metabolic pathways | Determining pathway contributions to ATP synthesis |
| CRISPR screen | Gene essentiality for ATP production or cell growth | Discovering new regulators of ATP biosynthesis |
| Respirometry | Mitochondrial oxygen consumption | Measuring oxidative phosphorylation capacity in isolated mitochondria |
| Western blot | Protein expression of ATP synthase subunits | Validating knockout or overexpression efficiency |
| Immunofluorescence | Subcellular localization of ATP synthase | Visualizing mitochondrial morphology and ATP synthase distribution |
Seahorse extracellular flux analysis
This method measures oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) to assess oxidative phosphorylation and glycolysis in live cells, providing real-time readouts of ATP production [1,3].
ATP luminescence assays
Luciferase-based ATP assays quantify total cellular ATP levels and can be used to evaluate the impact of genetic perturbations on ATP biosynthesis.
Metabolomics and flux analysis
Mass spectrometry-based metabolomics and isotope tracing allow researchers to map metabolic fluxes through glycolysis, the TCA cycle, and oxidative phosphorylation, revealing how genes affect ATP synthesis.
CRISPR screening
Genome-wide CRISPR knockout or activation screens coupled with ATP sensors or viability readouts can identify novel regulators of ATP biosynthetic process.
How CRISPR Can Be Used to Study GO:0006754 ATP biosynthetic process
Knockout
CRISPR knockout of genes such as ATP5F1A or PKM allows researchers to study their essential roles in ATP biosynthesis. Knockout cell lines can be analyzed for ATP levels, mitochondrial function, and viability, revealing compensatory mechanisms and synthetic lethality [1,3].
Point Mutation
Introducing disease-associated point mutations (e.g., in SDHA or NDUFA1) via CRISPR base editing or homology-directed repair enables precise modeling of mitochondrial disorders and assessment of their impact on ATP synthesis.
Knock-in
Knock-in of tagged versions of ATP synthase subunits (e.g., ATP5F1A-HA) facilitates affinity purification, imaging, and interaction studies, providing insights into the assembly and regulation of the ATP synthase complex.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like CKB or PKM can boost ATP production and rescue energy deficits in disease models, offering potential therapeutic strategies [1,3].
How EDITGENE Supports ATP biosynthetic process Research
Researchers studying ATP biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in energy metabolism, mitochondrial function, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for ATP biosynthetic process research.
Frequently Asked Questions About ATP biosynthetic process
What is ATP biosynthetic process?
ATP biosynthetic process (GO:0006754) is the set of chemical reactions and pathways that produce ATP, the main energy currency of the cell, through mechanisms such as substrate-level phosphorylation and oxidative phosphorylation.
What genes are involved in ATP biosynthetic process?
Key genes include ATP5F1A, ATP5F1B, PKM, GAPDH, CKB, NDUFA1, SDHA, and many others encoding enzymes of glycolysis, the TCA cycle, and oxidative phosphorylation [1,3].
How is ATP synthesized in mitochondria?
In mitochondria, ATP is synthesized by oxidative phosphorylation, where the electron transport chain creates a proton gradient that drives ATP synthase to produce ATP from ADP and inorganic phosphate.
What is the difference between substrate-level phosphorylation and oxidative phosphorylation?
Substrate-level phosphorylation directly transfers a phosphate group from a substrate to ADP, while oxidative phosphorylation uses the energy from electron transport and a proton gradient to synthesize ATP.
Which diseases are associated with defects in ATP synthesis?
Defects in ATP synthesis are linked to mitochondrial myopathies, neurodegenerative diseases, cardiotoxicity, and cancer metabolism [3,4].
How can CRISPR be used to study ATP biosynthetic process?
CRISPR can create knockout, point mutation, knock-in, and overexpression models to dissect the roles of specific genes in ATP production and to identify therapeutic targets [1,3].
What methods measure ATP production in cells?
Common methods include Seahorse extracellular flux analysis, ATP luminescence assays, metabolomics, and isotope tracing [1,3].
What is decarboxylation phosphorylation?
Decarboxylation phosphorylation is an ATP synthesis mechanism used by certain anaerobic bacteria, where the energy from decarboxylation reactions is coupled to ATP production.
Why is ATP important for cell function?
ATP provides energy for virtually all cellular processes, including muscle contraction, ion transport, biosynthesis, and signal transduction [1,2].
Can ATP synthesis be targeted for cancer therapy?
Yes, because cancer cells often reprogram their metabolism to rely on glycolysis for ATP, targeting ATP biosynthetic pathways is a potential therapeutic strategy.
Conclusion
ATP biosynthetic process (GO:0006754) is a cornerstone of cellular bioenergetics, encompassing diverse pathways that ensure a continuous supply of ATP for life-sustaining activities. Its dysregulation is implicated in numerous diseases, making it a critical area of research [3,4]. With advanced CRISPR tools and analytical methods, scientists can now dissect the genetic and molecular underpinnings of ATP synthesis with unprecedented precision. EDITGENE stands ready to support these efforts with tailored cell models and screening services.
References
- 1. Bonora M et al.. 2012. ATP synthesis and storage.. Purinergic Signal 8(3):343-57 PMID: 22528680
- 2. Burnstock G. 1976. Purine nucleotides.. Adv Biochem Psychopharmacol 15:225-35 PMID: 15417
- 3. Alan L et al.. 2022. Shaping fuel utilization by mitochondria.. Curr Biol 32(12):R618-R623 PMID: 35728541
- 4. Yıldırım E et al.. 2023. Protective effect of adenosine triphosphate and benidipine separately or together against cardiotoxicity caused by bevacizumab.. Biotech Histochem 98(3):193-200 PMID: 36484126
- 5. Dimroth P et al.. 2008. ATP synthesis by decarboxylation phosphorylation.. Results Probl Cell Differ 45:153-84 PMID: 18049805
- 6. Hedberg C et al.. 2015. Molecular perspectives on protein adenylylation.. ACS Chem Biol 10(1):12-21 PMID: 25486069
- 7. Burnstock G. 1977. The purinergic nerve hypothesis.. Ciba Found Symp PMID: 24531
- 8. Wittinghofer A. 2016. GTP and ATP hydrolysis in biology.. Biopolymers 105(8):419-21 PMID: 27135900
